KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Jazz Pharmaceuticals (JAZZ) Assets Average: 2009-2025

Historic Assets Average for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Sep 2025 value amounting to $11.2 billion.

  • Jazz Pharmaceuticals' Assets Average fell 5.58% to $11.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 billion, marking a year-over-year decrease of 5.58%. This contributed to the annual value of $11.7 billion for FY2024, which is 5.29% up from last year.
  • As of Q3 2025, Jazz Pharmaceuticals' Assets Average stood at $11.2 billion, which was down 0.79% from $11.2 billion recorded in Q2 2025.
  • Jazz Pharmaceuticals' Assets Average's 5-year high stood at $12.8 billion during Q3 2021, with a 5-year trough of $6.6 billion in Q1 2021.
  • Over the past 3 years, Jazz Pharmaceuticals' median Assets Average value was $11.3 billion (recorded in 2023), while the average stood at $11.4 billion.
  • In the last 5 years, Jazz Pharmaceuticals' Assets Average soared by 107.88% in 2021 and then dropped by 15.98% in 2022.
  • Quarterly analysis of 5 years shows Jazz Pharmaceuticals' Assets Average stood at $12.4 billion in 2021, then decreased by 14.36% to $10.6 billion in 2022, then increased by 6.49% to $11.3 billion in 2023, then grew by 7.39% to $12.1 billion in 2024, then dropped by 5.58% to $11.2 billion in 2025.
  • Its last three reported values are $11.2 billion in Q3 2025, $11.2 billion for Q2 2025, and $11.8 billion during Q1 2025.